FIELD: medicine.
SUBSTANCE: invention represents a method for preparing a drug substance of polyprenylphosphates and beta-sitosterol consisting in pre-mixing polyprenylphosphates and sorbitol in a mortar, a size of which fits the total volume of the mixed substances. Between a wall and/or a bottom of the mortar and the introduced polyprenylphosphates, there is a layer of sorbitol; the blended mixture of the polyprenylphosphates in sorbitol is homogenised. Sorbitol, a dry mixture of polyprenylphosphates in sorbitol in a ratio of 1:8 and beta-sitosterol are added into a homogeniser, and pulsed homogenisation is performed for 10 minutes. The homogenisation is performed at a rotation rate of 500-700 rpm for 4 minutes, 1000-1200 rpm for 2 minutes and then 500-600 rpm for 4 minutes; the rotation rate variation requires a pause of 20 minutes. Each pause of the process is followed by the intensive agitation of a mixture cup; the prepared powder is sieved at a mesh size of 20 mcm; if a sieving weight makes less than 0.1% of the weight of the loaded ingredients; the homogenisation process is terminated.
EFFECT: preparing the drug substance with the maximum effective concentration of the active substances uniformly weight-distributed and higher bioavailability.
3 cl, 2 ex, 1 tbl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
REMEDY FOR PREVENTION AND TREATMENT OF METABOLIC SYNDROME | 2022 |
|
RU2806867C1 |
AGENT FOR TREATING METABOLIC SYNDROME | 2014 |
|
RU2580757C1 |
BIOLOGICALLY ACTIVE ADDITIVE AND METHOD OF ITS MANUFACTURING | 2010 |
|
RU2427284C1 |
GYNOSTEMMA PENTAPHYLLUM COMPOSITION WITH HIGH PHARMACOLOGICAL ACTIVITY | 2013 |
|
RU2568883C2 |
AGENT FOR DISSOLUTION OF BILE STONES AND TREATMENT OF CHOLELITHIASIS | 2015 |
|
RU2605264C1 |
DRONE LARVA HOMOGENATE AND LYOPHILIZATE ELICITING HYPOLIPIDEMIC AND HEPATOPROTECTIVE ACTIVITY | 2002 |
|
RU2239443C2 |
COMPOSITION OF TRADITIONAL CHINESE MEDICINE, METHOD OF ITS PREPARATION AND ITS USE | 2021 |
|
RU2806632C1 |
THERAPEUTIC NUTRIENT COMPOSITION | 2014 |
|
RU2571815C1 |
PHARMACEUTICAL COMPOSITION, POSSESSING ANTICOAGULANT AND CHOLESTEROL-LOWERING PROPERTIES | 2007 |
|
RU2414907C2 |
ELIXIR SHOWING TOTAL TONIC AND ADAPTOGENIC ACTION | 2000 |
|
RU2171113C1 |
Authors
Dates
2015-02-20—Published
2014-03-13—Filed